Ameliorating effects and mechanisms of chronic electroacupuncture at ST36 in a rodent model of dyspepsia induced by cisplatin
- 23 September 2018
- journal article
- research article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 31 (1), e13474
- https://doi.org/10.1111/nmo.13474
Abstract
Background Chemotherapy‐associated dyspepsia syndrome (CADS) is among the most intensive side effects and critical concerns for patients with cancer. To investigate the effects and mechanisms of chronic electroacupuncture (EA) at ST36 on chemotherapy‐associated dyspeptic symptoms (CADS) in rats. Methods Cisplatin (8 mg/kg, ip) was given once to establish CADS model. EA or sham‐EA treatment was then performed one hour daily for 21 days. Key Results (a) EA treatment decreased kaolin intake within 24 hours (1.67 ± 0.23 g vs 2.36 ± 0.37 g in sham‐EA, P < 0.05); EA increased food intake (9.43 ± 2.28 vs 4.32 ± 1.26 in sham‐EA, P < 0.05) and cisplatin‐induced reduction of body weight (426.38 ± 13.25 vs 407.92 ± 13.26 in sham‐EA, P = 0.05). (b) The incidence of normal behavioral satiety sequence (53%) in EA group was greater than that in sham‐EA (32%) group (X2 = 17.68, P < 0.01). (c) EA increased the percentage of normal gastric slow waves (82.6 ± 5.98 vs 22.8 ± 1.90 in sham‐EA, P < 0.05). (d) EA normalized cisplatin delayed gastric emptying (71.3% ± 6.8% vs 44.6% ± 11.2% in control, P < 0.05). (e) EA decreased ratio of heart rate variability (0.30 ± 0.03 vs 0.56 ± 0.05 in sham‐EA, P < 0.05). (f) EA decreased fasting ghrelin, glucagon‐like peptide‐1 and peptide YY (P < 0.01 vs sham‐EA for all). Conclusions and Inferences Chronic EA ameliorates dyspepsia symptom and improves gastric dysmotility induced by Cisplatin, mediated via the vagal and gastrointestinal hormonal mechanisms.Funding Information
- Shannxi National Science Foundation ((No: 2018JM7148))
- Shannxi Traditional Chinese Medicine administration Foundation ((No: JCMS004))
This publication has 51 references indexed in Scilit:
- Gut Hormones, Appetite Suppression and Cachexia in Patients with Pulmonary TBPLOS ONE, 2013
- The LF/HF ratio does not accurately measure cardiac sympatho-vagal balanceFrontiers in Physiology, 2013
- Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort studyBMC Health Services Research, 2012
- Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patientsInternational Journal of Clinical Oncology, 2011
- Heart Rate Variability ? A Historical PerspectiveFrontiers in Physiology, 2011
- Endurance Exercise Training Reduces Cardiac Sodium/Calcium Exchanger Expression in Animals Susceptible to Ventricular FibrillationFrontiers in Physiology, 2011
- Pharmacological Management of Chemotherapy-Induced Nausea and VomitingDrugs, 2009
- The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptomsThe Esophagus, 2005
- Physiological and behavioural responses to duodenal pain in freely moving ratsPhysiology & Behavior, 2004
- Cancer and chemotherapy-related upper gastrointestinal symptoms: the role of abnormal gastric motor function and its evaluation in cancer patientsSupportive Care in Cancer, 2002